Evaxion Biotech AS (EVAX)
2.64
+0.05
(+1.93%)
USD |
NASDAQ |
Nov 04, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Total Assets (Quarterly): 15.18M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 15.18M |
| June 30, 2024 | 15.23M |
| March 31, 2024 | 22.65M |
| December 31, 2023 | 12.89M |
| September 30, 2023 | 11.94M |
| June 30, 2023 | 16.75M |
| March 31, 2023 | 20.49M |
| December 31, 2022 | 22.02M |
| September 30, 2022 | 27.45M |
| Date | Value |
|---|---|
| June 30, 2022 | 34.00M |
| March 31, 2022 | 41.08M |
| December 31, 2021 | 40.16M |
| September 30, 2021 | 24.12M |
| June 30, 2021 | 27.66M |
| March 31, 2021 | 34.92M |
| December 31, 2020 | 11.96M |
| September 30, 2020 | 11.28M |
| December 31, 2019 | 11.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.08M
Minimum
Dec 2019
41.08M
Maximum
Mar 2022
22.27M
Average
21.26M
Median
Total Assets (Quarterly) Benchmarks
| Ascendis Pharma AS | 812.82M |
| Novo Nordisk AS | 53.03B |
| DBV Technologies SA | 114.19M |
| Adaptimmune Therapeutics PLC | 321.70M |
| Akari Therapeutics PLC | 5.076M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.18M |
| Shareholders Equity (Quarterly) | 0.074M |
| Net Debt Paydown Yield | 8.20% |